why choose us

First received: May 15, 2025

Clinical Trial: A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Weight Management

Study Type: INTERVENTIONAL


Official Title: A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity or Overweight With

Brief Summary: This randomized, double-blind, placebo-controlled phase IIa study is designed to evaluate the efficacy, safety, and tolerability of ASC30 Tablets and ASC30 Tablets A1.

Read more